https://library.ehaweb.org/eha/2024/eha2024-congress/4136517/abhishek.maiti.ela026.targeting.of.sirp282B29.immune.cells.results.in.a.high.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Amarker%3D5097%2Afeatured%3D18527
Dr Maiti presenting positive data from a different phase 1 trial next week at EHA2024.
https://faculty.mdanderson.org/profiles/abhishek_maiti.html
Impressive guy. 23 honours and awards listed. This one caught my attention.
2020 ASCO Endowed Merit Award, ASCO Bristol-Myers Squibb.
He has played a role in 79 peer reviewed articles.
This is the same guy who approached us because recent data and synergies with our NK cells were just too compelling.
- Forums
- ASX - By Stock
- Ann: Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA
https://library.ehaweb.org/eha/2024/eha2024-congress/4136517/abhi...
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.76M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.8¢ | $7.224K | 394.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 524782 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 579591 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 524782 | 0.018 |
3 | 707660 | 0.017 |
12 | 3472701 | 0.016 |
13 | 4840065 | 0.015 |
5 | 2331428 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 579591 | 4 |
0.020 | 1114755 | 4 |
0.021 | 488333 | 3 |
0.022 | 300000 | 2 |
0.023 | 155000 | 2 |
Last trade - 15.32pm 12/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |